POSB158 Cost-Effectiveness of Obinutuzumab Combined with Chemotherapy As Induction Therapy and Followed By Obinutuzumab Maintenance Therapy for Treatment Naïve Patients with Advanced Follicular Lymphoma in Mainland China
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.431
https://www.valueinhealthjournal.com/article/S1098-3015(21)02226-9/fulltext
Title :
POSB158 Cost-Effectiveness of Obinutuzumab Combined with Chemotherapy As Induction Therapy and Followed By Obinutuzumab Maintenance Therapy for Treatment Naïve Patients with Advanced Follicular Lymphoma in Mainland China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02226-9&doi=10.1016/j.jval.2021.11.431
First page :
Section Title :
Open access? :
No
Section Order :
11207